Symbiosis Pharmaceutical Services, a worldwide sterile fill/finish contract manufacturing organization (CMO), has successfully passed its recent audit conducted by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA). This follows an inspection of its newly constructed Bruce Building, a 20,000 sq ft aseptic facility that contains an automated fill/finish line for the sterile production of injectable drug products, including both small molecules and biologics. This successful au...